“Both Presidents Trump and Biden have put forth initiatives to end HIV with calls for increased funding for testing, treatment, and prevention, including for PrEP. However, it is necessary for Congress to commit to the investments as well,” said Carl Schmid. “While there have been some increases, they have not been at the level needed to put the U.S. on a path to end HIV. This will result in new infections, more people living with HIV, and the need to provide lifetime care and treatment.”
New HIV infection rates drop thanks to progress in young people, but US still not on track
“It appears that our investments in HIV prevention are providing some positive results, but the persistent high number of new diagnoses and the low usage of PrEP among the communities most impacted by HIV point to the need for increased resources, particularly for a national PrEP program,” Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, said in a statement.
New CDC data shows HIV infections dropped, but mostly among whites
The HIV+Hepatitis Policy Institute issued a press release following the CDC’s announcement of the new data, noting both the encouraging progress and need for improvement. “It appears that our investments in HIV prevention are providing some positive results, but the persistent high number of new diagnoses and the low usage of PrEP among the communities most impacted by HIV point to the need for increased resources, particularly for a national PrEP program,” said the group’s executive director, Carl Schmid.
‘The stakes are really high.’ Judge’s ruling could affect free cancer screenings for millions
The ruling eliminating preventive coverage without cost sharing for PrEP on religious grounds shows “clear bias,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. Some states have passed laws that will continue to require coverage of ACA-mandated preventive services even if the federal protections are eliminated.
Texas judge’s ruling that threatens PrEP access paused by Appeals Court
Executive director of the HIV and Hepatitis Policy Institute Carl Schmid tells The Advocate that it’s important for people to know that while the ruling is stayed, access to preventative care, including PrEP, has not changed. His organization will file an amicus brief with the appeals court in June in opposition to the lower court’s ruling.